Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Up 100.0% in November

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPYGet Free Report) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 200 shares, an increase of 100.0% from the October 31st total of 100 shares. Based on an average trading volume of 600 shares, the short-interest ratio is presently 0.3 days.

Hikma Pharmaceuticals Price Performance

Shares of OTCMKTS HKMPY traded down $0.84 during mid-day trading on Friday, reaching $50.64. 633 shares of the company traded hands, compared to its average volume of 711. Hikma Pharmaceuticals has a fifty-two week low of $43.68 and a fifty-two week high of $55.56. The stock has a fifty day simple moving average of $49.45 and a 200-day simple moving average of $50.15.

About Hikma Pharmaceuticals

(Get Free Report)

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

Featured Articles

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.